![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LumiraDx Gains CE Mark for COVID-19 Test
LumiraDx Gains CE Mark for COVID-19 Test
![LumiradxLogo.png](https://www.fdanews.com/ext/resources/test/Device_Images6/LumiradxLogo.png?t=1597975244&width=430)
London-based LumiraDx has earned CE mark certification for its RNA STAR Complete COVID-19 test.
The assay, for which the FDA granted Emergency Use Authorization in October, is intended to support rapid testing programs in full-scale laboratories and mobile lab units.
The RNA test uses a direct amplification method that combines cell breakdown and amplification in a single step, detecting viral nucleic acid in 20 minutes or less on common polymerase chain reaction systems, the company said.
Upcoming Events
-
21Oct